In contrast, brain, pancreas, lung, liver, large intestine, kidney, and adipose tissue from homozygous GIPR/GLP1R humanized mice all showed negative staining for mouse GLP1R, confirming effective disruption of the endogenous mouse gene
It is important to emphasize that Retatrutide remains an investigational drug and is not yet approved for general clinical use
Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial
Another is by subjecting its products to trials, which Pendulum has also done, with good tolerability among participants
Faillie et al
Eur J Gastroenterol Hepatol 2000;12:1347-52.ArticlePubMed 41